Status
Conditions
Treatments
About
Lifelong oral anticoagulant (OAC) therapy is the preferred treatment for the prevention of thromboembolic events in the majority of patients with Atrial Fibrillation (AF). Adherence to medication is essential for valid treatment for OAC therapy.
The study aims to explore whether the advanced educational intervention would improve the adherence to dabigatran.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Patients can be included if ALL the following criteria are met:
Exclusion criteria
Patients should not be included if ANY ONE of the following criteria is met:
897 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal